Very Low Calorie Diets (VLCD's) should only be used where rapid weight loss is essential to health and wellbeing as recommended and supervised by medical professionals experienced in the use of modified fasting.
Product Description
VANILLA OPTIFAST VLCD
Formerly Modifast
Optifast VLCD Sachets - Vanilla
21x 40gm
Presentation: Packs of twenty one sachets (one week supply) of powder formula in vanilla flavour.
Uses:
Total food replacement for the overweight. Optifast„µ VLCD is intended for use as part of the management of the moderately to severely overweight, even when there is associated secondary pathology e.g. non-insulin-dependent diabetes, hypertension, osteoarthritis, hypothyroidism corrected by replacement therapy, gynaecological disorders, hyperlipidaemia or where obesity is an impediment to surgery.
Monitoring:
At the commencement of treatment, patients should be checked for normal renal and hepatic function and thereafter regular checks for weight, blood pressure and urinalysis.
Ingredients
Vanilla. Contains caseinates (milk protein), non-fat milk solids, sugar, maltodextrin, sunflower oil, flavours, colour (160a), emulsifier (322), saccharin sodium, antioxidant and micronutrients as listed in Table 1
Optifast VLCD: Table 1
Typical Analysis per 40g sachet
Energy 638 kJ (152 Cal)
Protein 17.3 g
Fat 2.3 g
Carbohydrate - total
- sugars 15.0 g
11.8 g
Calcium (total) 300 mg
Sodium (total) 332 mg
Potassium (total) 668 mg
Added Nutrients per 40g sachet
Retinyl acetate (Vitamin A acetate) 333 microgram (1,100 IU)
Thiamine HCl (Vitamin B1) 530 microgram
Riboflavine (Vitamin B2) 667 microgram
Nicotinamide 6 mg
Pantothenic acid (Vitamin B5) 2.67 mg
Pyridoxine HCl (Vitamin B6) 667 microgram
Cyanocobalamin (Vitamin B12) 1 microgram
Ascorbic acid (Vitamin C) 25 mg
Cholecalciferol (Vitamin D3) 1.667 microgram (66.67 IU)
dl-alpha-Tocopherol (Vitamin E) 4 mg (4.4 IU)
Biotin (Vitamin H) 67 microgram
Phytomenadione (Vitamin K1) 33 microgram
Folic acid 133 microgram
Calcium (added only ¡V not total) 17 mg
Chromium 33 microgram
Copper 833 microgram
Iron 5 mg
Magnesium 116 mg
Manganese 1 mg
Molybdenum 67 microgram
Iodine 50 microgram
Potassium (added only ¡V not total) 463 mg
Selenium (inorganic form) 17 microgram
Sodium (added only ¡V not total) 166 mg
Zinc 5 mg
Warnings
Contraindications:
Acute cerebrovascular or cardiovascular disease, renal disease, hepatic disease, juvenile onset diabetes, porphyria or overt psychosis.
Use in pregnancy. Contraindicated.
Use in lactation. Contraindicated.
Use in children. Modified fasting is not recommended for treatment of childhood weight problems. Selenium-containing products are not suitable for use by children under the age of 15 years.
Precautions:
Patients with recent myocardial infarction should be referred to a cardiologist to determine suitability for modified fasting. Patients should be screened for gall bladder disorders prior to commencement of modified fasting using Optifast„µ VLCD.
Patients receiving medication for diabetes, hypertension, hyperlipidaemia or those on lithium therapy may require a reduction in dose or withdrawal of treatment whilst undergoing modified fasting. Such patients should be monitored carefully in the first weeks of a Optifast„µ VLCD program.
Patients with a history of hepatic or renal disease should also be monitored carefully.
Patients on lithium therapy require more frequent monitoring of blood lithium levels.
Alcohol should not be consumed when using Optifast VLCD.
Top of Form 1
Bottom of Form 1
Very Low Calorie Diets (VLCD's) should only be used where rapid weight loss is essential to health and wellbeing as recommended and supervised by medical professionals experienced in the use of modified fasting.
Product Description
CHOCOLATE OPTIFAST VLCD
Formerly Modifast
Optifast VLCD Sachets - Chocolate
21x 40gm
Presentation: Packs of twenty one sachets (one week supply) of powder formula in chocolate flavour.
Uses:
Total food replacement for the overweight. Optifast„µ VLCD is intended for use as part of the management of the moderately to severely overweight, even when there is associated secondary pathology e.g. non-insulin-dependent diabetes, hypertension, osteoarthritis, hypothyroidism corrected by replacement therapy, gynaecological disorders, hyperlipidaemia or where obesity is an impediment to surgery.
Monitoring:
At the commencement of treatment, patients should be checked for normal renal and hepatic function and thereafter regular checks for weight, blood pressure and urinalysis.
Ingredients
Chocolate. Contains caseinates (milk protein), non-fat milk solids, maltodextrin, sugar, cocoa, sunflower oil, flavours, colour (160a), emulsifier (322), saccharin sodium, antioxidant and micronutrients as listed in Table 1
Typical Analysis Table 1
per 40g sachet
Energy 638 kJ (152 Cal)
Protein 17.3 g
Fat 2.3 g
Carbohydrate - total
- sugars 15.0 g
11.8 g
Calcium (total) 300 mg
Sodium (total) 332 mg
Potassium (total) 668 mg
Added Nutrients per 40g sachet
Retinyl acetate (Vitamin A acetate) 333 microgram (1,100 IU)
Thiamine HCl (Vitamin B1) 530 microgram
Riboflavine (Vitamin B2) 667 microgram
Nicotinamide 6 mg
Pantothenic acid (Vitamin B5) 2.67 mg
Pyridoxine HCl (Vitamin B6) 667 microgram
Cyanocobalamin (Vitamin B12) 1 microgram
Ascorbic acid (Vitamin C) 25 mg
Cholecalciferol (Vitamin D3) 1.667 microgram (66.67 IU)
dl-alpha-Tocopherol (Vitamin E) 4 mg (4.4 IU)
Biotin (Vitamin H) 67 microgram
Phytomenadione (Vitamin K1) 33 microgram
Folic acid 133 microgram
Calcium (added only – not total) 17 mg
Chromium 33 microgram
Copper 833 microgram
Iron 5 mg
Magnesium 116 mg
Manganese 1 mg
Molybdenum 67 microgram
Iodine 50 microgram
Potassium (added only – not total) 463 mg
Selenium (inorganic form) 17 microgram
Sodium (added only – not total) 166 mg
Zinc 5 mg
Warnings
Contraindications:
Acute cerebrovascular or cardiovascular disease, renal disease, hepatic disease, juvenile onset diabetes, porphyria or overt psychosis.
Use in pregnancy. Contraindicated.
Use in lactation. Contraindicated.
Use in children. Modified fasting is not recommended for treatment of childhood weight problems. Selenium-containing products are not suitable for use by children under the age of 15 years.
Precautions:
Patients with recent myocardial infarction should be referred to a cardiologist to determine suitability for modified fasting. Patients should be screened for gall bladder disorders prior to commencement of modified fasting using Optifast VLCD.
Patients receiving medication for diabetes, hypertension, hyperlipidaemia or those on lithium therapy may require a reduction in dose or withdrawal of treatment whilst undergoing modified fasting. Such patients should be monitored carefully in the first weeks of a Optifast VLCD program.
Patients with a history of hepatic or renal disease should also be monitored carefully.
Patients on lithium therapy require more frequent monitoring of blood lithium levels.
Alcohol should not be consumed when using Optifast VLCD.
AUST L 500851
AUST L 500863 EXP 07/2010 or later
Out side of N,S,W they will not be sent in the boxs as it is too expensive ,The will be posted by 3kg express bag. |
Back to home page
) 
Print
Report item
